News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
28 Results
Type
Article (4)
Press Release (24)
Section
Business (13)
Deals (3)
Drug Development (6)
News (21)
Tag
Alliances (2)
Clinical research (3)
Earnings (1)
Events (4)
IPO (1)
Mergers & acquisitions (2)
People (8)
Phase I (3)
Phase II (1)
Preclinical (2)
Startups (2)
Date
2021 (2)
2019 (1)
2017 (2)
2015 (4)
2014 (1)
2013 (2)
2012 (3)
2011 (3)
2010 (4)
28 Results for "suppremol".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
SuppreMol Appoints Industry Expert Klaus Schollmeier as CEO
April 3, 2013
·
3 min read
SuppreMol’s Clinical Data In SLE For Its Lead Product SM101 Accepted For Presentation At The 2014 ACR / ARHP Annual Meeting In Boston
September 9, 2014
·
2 min read
Business
SuppreMol Employs Protagen AG Biomarkers in SLE Study
August 2, 2011
·
4 min read
Drug Development
SuppreMol Begins Development of Anti-IL-3 Monoclonal Antibody to Diagnose and Treat Early Stage Rheumatoid Arthritis
July 27, 2012
·
3 min read
Drug Development
SuppreMol Releases Positive Interim Phase Ib/IIa Results on SM101 in Primary Immune Thrombocytopenia (ITP) Trials
March 15, 2012
·
3 min read
SuppreMol Receives U.S. Orphan Drug Designation for SM101
April 23, 2010
·
1 min read
Business
SuppreMol Appoints Dr. Robert Phelps as Head of Business Development & Licensing
February 8, 2010
·
1 min read
Business
SuppreMol Announces Expansion of its Management Team and Board Changes
October 21, 2008
·
3 min read
Drug Development
SuppreMol Initiates Phase Ib/Iia Clinical Trial With Its Lead Candidate SM101
April 14, 2010
·
1 min read
Drug Development
SuppreMol Receives Orphan Drug Designation for SM101
September 12, 2007
·
3 min read
1 of 3
Next
